Učitavanje...
Challenges and advances in the assessment of the disposition of antibody‐drug conjugates
Antibody‐drug conjugates (ADCs) are a rapidly growing therapeutic platform for the treatment of cancer. ADCs consist of a cytotoxic small molecule drug linked to an antibody to provide targeted delivery of the cytotoxic agent to the tumor. Understanding the pharmacokinetics (PK) and pharmacodynamics...
Spremljeno u:
| Izdano u: | Biopharm Drug Dispos |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley and Sons Inc.
2015
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5032988/ https://ncbi.nlm.nih.gov/pubmed/25904406 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/bdd.1957 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|